["Lysoneuro" in cephalalgic syndromes. Evaluation of 282 cases followed up in ambulatory care].
D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D000596:Amino Acids / Q000627:therapeutic use; D000605:Amino Alcohols / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use*; D001688:Biological Products / Q000627:therapeutic use; D001920:Bradykinin / Q000037:antagonists & inhibitors; D002986:Clinical Trials as Topic; D004873:Ergolines / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D006261:Headache / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012702:Serotonin Antagonists; D014653:Vascular Headaches / Q000188:drug therapy
D000596:Amino Acids; D000605:Amino Alcohols; D000700:Analgesics; D001688:Biological Products; D004873:Ergolines; D012702:Serotonin Antagonists; D001920:Bradykinin
Il "Lysoneuro" nelle sindromi cefalalgiche. Valutazione di una casistica di 282 pazienti seguiti ambulatoriamente.